13.55

0.37% 0.05

After Hours: 13.55

Third Harmonic Bio Inc (THRD)

Overview News Price History Option Chain Financials Discussions Forecast

Third Harmonic Bio Inc stock is traded at $13.55, with a volume of 92,713. It is up +0.37% in the last 24 hours and up +17.32% over the past month. Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

Previous Close:

$13.50

Open:

$13.42

24h Volume:

92,713

Relative Volume:

0.61

Market Cap:

$546.66M

Revenue:

Net Income/Loss:

$-32.74M

P/E Ratio:

-8.6207

EPS:

-1.5718

Net Cash Flow:

$-24.89M

1W Performance:

-1.31%

1M Performance:

+17.32%

6M Performance:

+43.54%

1Y Performance:

+112.05%

1-Day Range:

$13.10

$13.97

1-Week Range:

$13.10

$14.78

52-Week Range:

$5.765

$16.94

Third Harmonic Bio Inc Stock (THRD) Company Profile

Name

Third Harmonic Bio Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

(209) 727-2457

Address

1700 MONTGOMERY STREET, SAN FRANCISCO

Employee

Twitter

Next Earnings Date

Latest SEC Filings

THRD's Discussions on Twitter

Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-16-22	Downgrade	Jefferies	Buy → Hold
Dec-15-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Oct-10-22	Initiated	Cowen	Outperform
Oct-10-22	Initiated	Jefferies	Buy
Oct-10-22	Initiated	Morgan Stanley	Overweight

Third Harmonic Bio Inc Stock (THRD) Latest News

Sep 25, 2024

WAVE Life Sciences (NASDAQ:WVE) Stock Quotes, Forecast and News Summary - Benzinga

Sep 25, 2024

Sep 22, 2024

Long Term Trading Analysis for (THRD) - Stock Traders Daily

Sep 22, 2024

Sep 20, 2024

Third harmonic bio executive sells over $140k in stock By Investing.com - Investing.com South Africa

Sep 20, 2024

Third harmonic bio executive sells over $140k in stock By Investing.com - Investing.com Australia

Sep 20, 2024

Third Harmonic Bio executive sells shares worth over $71,000 By Investing.com - Investing.com Australia

Sep 20, 2024

Third Harmonic Bio executive sells shares worth over $71,000 By Investing.com - Investing.com Canada

Sep 20, 2024

Third Harmonic Bio executive sells shares worth over $71,000 - Investing.com India

Sep 20, 2024

Third Harmonic Bio executive sells shares worth over $71,000 - Investing.com

Sep 20, 2024

Victory Capital Management Inc. Has $1.14 Million Position in Hamilton Lane Incorporated (NASDAQ:HLNE) - Defense World

Sep 20, 2024

Highbridge Capital Management LLC Purchases Shares of 630,114 HashiCorp, Inc. (NASDAQ:HCP) - MarketBeat

Sep 20, 2024

Independent directors resign from 23andMe board after opposing move to privatize - Washington Times

Sep 19, 2024

23andMe Stock Falls as All Board Members Resign - Barron's

Sep 19, 2024

Finnish Authorities Are After Hex And PulseChain Founder, Richard Heart On Suspicion Of Tax Evasion And Assault - 99Bitcoins

Sep 19, 2024